Digital Biomarkers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Digital Biomarkers Market Report is Segmented by Type (Data Collection Tools and Data Integration Tools), Clinical Practice (Monitoring Digital Biomarkers, Diagnostic Digital Biomarkers, Predictive and Prognostic Digital Biomarkers, and Other Clinical Practices), Therapeutic Area (Cardiovascular and Metabolic Disorders, Respiratory Disorders, Neurological Disorders, Musculoskeletal Disorders, and Other Therapeutic Areas), End User (Pharmaceutical Companies, Healthcare Providers, Payers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Report Offers the Values (USD) for all the Above Segments.

Digital Biomarkers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Digital Biomarkers Industry Overview

The digital biomarkers market is semi-consolidated in nature due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Major market players include Akili Inc., ActiGraph LLC, AliveCor Inc., Fitbit Health Solutions, Empatica Inc., Biogen, F. Hoffmann-La Roche Ltd, Koneksa, IXICO PLC, and Huma.

Digital Biomarkers Market Leaders

  1. ActiGraph

  2. Fitbit Health Solutions

  3. Biogen

  4. F. Hoffmann-La Roche Ltd.

  5. Huma

  6. *Disclaimer: Major Players sorted in no particular order
Digital Biomarkers Market Concentration